An observational study in Wounds, Pressure Ulcer and Diabetic Foot Ulcer, sponsored by Kerecis Ltd.. Enrolling by invitation at 5 sites in United States. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Kerecis Ltd. (part of Coloplast A/S) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 130 studies in Surgical Wound with a site in United States — 18 open to participants now, 22 under way, none of them phase 3. Surgical Wound · United States.
Among the 130 studies in Surgical Wound with a site in United States, this one has the largest planned enrollment of the 19 observational ones that give a count, is one of 6 that started in 2024, is one of 19 observational ones, reaches primary completion later than 7 of the 21 other live ones, and was the 117th registered.
315 studies on the registry are indexed under Surgical Wound; 57 are open to participants now.
Browse Surgical Wound studies →18 of the 130 studies in Surgical Wound with a site in United States are open now. Recruiting first, the newest first:
Integra LifeSciences Corporation · Sites in United States
Ages 21+
The Metis Foundation · Sites in United States
Ages 18–85
Acera Surgical, Inc. · Sites in United States
Ages 18+
University of Nevada, Las Vegas · Sites in United States
Ages 18+ · Healthy volunteers
Hospital for Special Surgery, New York · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 34 Surgical Wound studies recruiting now, 20 (59%) set no upper age limit and 10 (29%) stop at 75 or younger; 6 take children under 18; 7 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
130 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 5 · Phase 3 4 · Phase 4 11
First in 2004; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 600 is above the median of 72 across 51 observational studies indexed under Surgical Wound.
Median enrollment 50 across the 111 interventional studies, 48 across the 19 observational. Of the 87 that completed or were terminated, 43 (49%) have results posted.
This tab as a report to print or save as PDF → With an account.
46 of 130 have an industry lead sponsor. The 10 most frequent:
This study is registered under Kerecis Ltd., one of the names counted as Coloplast A/S. Under that name alone:
Kerecis Ltd. is the lead sponsor of 14 studies on the registry; 3 are open to participants now.
Coloplast A/S has 1 study filed under Surgical Wound — fewer than ten, so there is no comparison to draw.
10 of the studies in Surgical Wound with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06259409Progenerative Medical, IncRegenn® Therapy System Safety Study | 2026-12 |
| NCT06384183Kerecis Ltd.Kerecis Real-World Fish Skin Graft Registry | 2026-12 |
| NCT04718168W.L.Gore & AssociatesGORE® ENFORM Biomaterial Product Study | 2026-12 |
| NCT06014411Hospital for Special Surgery, New YorkEarly Versus Delayed Bathing of Orthopaedic Surgical Wounds | 2026-12 |
| NCT07653165West Boca Center for Wound HealingUse of Hydroprep Wound Therapy With Motion Negative Pressure Therapy for Treatment of Chronic Lower Extremity Wounds | 2026-12-31 |
Add all 10 to your calendar (.ics) → With an account.
Among the 130 studies in Surgical Wound with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Multi-center, observational (i.e., non-interventional), open-label, real-world Registry on the Use of Kerecis Devices
This observational (i.e., non-interventional), post-market, real-world, Registry was designed to collect, analyze, and identify relevant safety and performance outcomes for "all comers" using Kerecis devices in routine medical practice within a wide variety of United States (US) medical practice settings. These clinical data will be used at Kerecis for many purposes, which include, but are not limited to, device safety and performance evaluation as part of routine patient care and post-market clinical follow-up data commitments to regulatory authorities around the world.
315 studies on the registry are indexed under Surgical Wound; 57 are open to participants now.
This study's planned enrollment of 600 is above the median of 72 across 51 observational studies indexed under Surgical Wound.
Browse Surgical Wound studies →Kerecis Ltd. is the lead sponsor of 14 studies on the registry; 3 are open to participants now.
First submitted after Kerecis Ltd. became part of Coloplast A/S.
Compared within Surgical Wound, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Wounds and Injuries. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Investigators will only enter previously collected clinical data from patients (all ages, demographics, and any health status) who meet all inclusion criteria and no exclusion criteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This observational (i.e., non-interventional), post-market, real-world, Registry was designed to collect, analyze, and identify relevant safety and performance outcomes for "all comers" using Kerecis devices in routine medical practice within a wide variety of United States (US) medical practice settings.
Device: Kerecis Fish Skin Graft
Patients already treated with a Kerecis device
Fish Skin Graft Device Related failure
Proportion of patients with Kerecis FSG device-related failure for any reason (e.g., resulting in non-absorption or device removal)
Time frame: 12 months
Fish Skin Graft Device related allergy
Proportion of patients with Kerecis FSG device-related allergy, hypersensitivity and/or autoimmune reaction (with or without documented auto-antibody development)
Time frame: 12 months
Target Wound Infection
Proportion of patients who develop target wound infection
Time frame: 12 months
Complete Wound Healing
The Time in weeks to complete healing
Time frame: 12 months
Complete Wound Closure
Proportion of participants who experience complete wound closure
Time frame: 12 months
Plan to share: Undecided — To be determined
No publications or documents are linked to this record.
Started Aug 2024 (actual). Primary completion is estimated for Dec 2026, 28 months after the start.
Of 32 observational studies under Surgical Wound, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 143. This study's planned 28 months is above that.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Jun 2026 → Dec 2026 and completion Jun 2027 → Dec 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.